期刊文献+

Avastin对肺癌诱导的肺微血管生成的影响 被引量:1

Bevacizumab (Avastin) inhibits lung cancer-induced pulmonary microvascular angiogenesis
下载PDF
导出
摘要 目的建立肺微血管内皮三维培养系统,观察抗血管内皮生长因子(VEGF)的人源化单克隆抗体Avastin对肺癌诱导的肺微血管生成的效应,并探讨其作用机制。方法通过血管生成抑制实验和采用流式细胞仪检测细胞周期和凋亡率的变化,观察Avastin对肺微血管内皮细胞的影响。结果随着Avastin作用浓度的增加,无血管结构区域的面积亦增加,由25μg/ml时的(0.944±0.073)cm2增加为100μg/ml的(5.189±0.192)cm2,凋亡率亦由(32.5±1.5)%增加为(39.2±1.6)%,并阻滞LVEC于G0/1期边界,造成细胞周期停滞,同时引起S期和G2/M期细胞比例显著降低。结论Avastin可抑制肺癌诱导的肺微血管内皮细胞的生长,并诱导细胞凋亡的发生,可能与Avastin阻滞LVEC于G0/1期边界,造成细胞周期停滞有关。 Objective To study the effect of bevacizumab (Avastin) on pulmonary microvascular angiogenesis induced by lung cancer. Methods The effects of Avastin on cell growth, cell cycle and apoptosis of lung microvascular endothelial cells were assayed by flow cytometry. Results Avastin inhibited the growth of lung microvascular endothelial cells and induced increase of cell apoptosis index in a concentration-dependent manner. With the increment of Avastin concentration from 25 to 100μg/ml, avascular area increased from 0.944±0.073 cm^2 to 5.189±0.192 cm^2, and the cell apoptosis index increased from 32.5% ±1.5% to 39.25±1.6%. Conclusion Avastin can inhibit the growth and induce apoptosis of lung microvascular endothelial cells in three-dimensional culture, possibly in association with cell cycle arrest in G0/1 phase.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2006年第7期1027-1029,1043,共4页 Journal of Southern Medical University
关键词 AVASTIN 血管内皮 肺癌 三维培养 Avastin vascular endothelium lung cancer three-dimensional culture
  • 相关文献

参考文献8

  • 1Isobe T,Herbst RS,Onn A.Current management of advanced nonsmall cell lung cancer:targeted therapy[J].Semin Oncol,2005,32(3):315-28. 被引量:1
  • 2Mio T,Adachi Y,Romberger DJ,et al.Regulation of fibroblast proliferation in three dimensional collagen gel matrix[J].In vitro Cell Dev Biol,1996,32:427-33. 被引量:1
  • 3王关嵩,蔡文琴,钱桂生,关崧.肺微血管内皮细胞系的建立及脂多糖作用后酪氨酸激酶受体活性的变化[J].第三军医大学学报,2003,25(2):94-97. 被引量:20
  • 4Midgley R,Kerr D.Bevacizumab-current status and future directions[J].Ann Oncol,2005,16(7):999-1004. 被引量:1
  • 5Singhal S,Vachani A,Antin-Ozerkis D,et al.Prognostic implications of cell cycle,apoptosis,and angiogenesis biomarkers in non-small cell lung cancer:a review[J].Clin Cancer Res.2005,11(11):3974-86. 被引量:1
  • 6Neri D,Bicknell R.Tumour vascular targeting[J].Nat Rev Cancer.2005,5(6):436-46. 被引量:1
  • 7Tozer GM,Kanthou C,Baguley BC.Disrupting tumour blood vessels[J].Nat Rev Cancer,2005,5.(6):423-35. 被引量:1
  • 8Fayette J,Soria JC,Armand JP.Use ofangiogenesis inhibitors in tumour treatment[J].Eur J Cancer,2005,41(8):1109-16. 被引量:1

二级参考文献2

共引文献19

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部